标题/作者	年份
Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units LS Shekerdemian, NR Mahmood, KK Wolfe, BJ Riggs, CE Ross, ... JAMA pediatrics 174 (9), 868-873	2020
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies A Sharma, S Tiwari, MK Deb, JL Marty International journal of antimicrobial agents 56 (2), 106054	2020
The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19 FK Yoshimoto The protein journal 39 (3), 198-216	2020
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons SH Nile, A Nile, J Qiu, L Li, X Jia, G Kai Cytokine & growth factor reviews 53, 66-70	2020
First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain S Iftimie, AF López-Azcona, I Vallverdú, S Hernández-Flix, G de Febrer, ... PloS one 16 (3), e0248029	2021
Clinical and pathological investigation of patients with severe COVID-19 S Li, L Jiang, X Li, F Lin, Y Wang, B Li, T Jiang, W An, S Liu, H Liu, P Xu, ... JCI insight 5 (12)	2020
Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2 MM Ghahremanpour, J Tirado-Rives, M Deshmukh, JA Ippolito, ... ACS medicinal chemistry letters 11 (12), 2526-2533	2020
Clinical update on COVID‐19 in pregnancy: A review article GA Ryan, NC Purandare, FM McAuliffe, M Hod, CN Purandare Journal of Obstetrics and Gynaecology Research 46 (8), 1235-1245	2020
COVID-19: Progress in diagnostics, therapy and vaccination X Liu, C Liu, G Liu, W Luo, N Xia Theranostics 10 (17), 7821	2020
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment P Tarighi, S Eftekhari, M Chizari, M Sabernavaei, D Jafari, P Mirzabeigi European Journal of Pharmacology 895, 173890	2021
High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents P Kanjanasirirat, A Suksatu, S Manopwisedjaroen, B Munyoo, P Tuchinda, ... Scientific reports 10 (1), 19963	2020
Role of Lopinavir/Ritonavir in the treatment of Covid-19: a review of current evidence, guideline recommendations, and perspectives S Meini, A Pagotto, B Longo, I Vendramin, D Pecori, C Tascini Journal of clinical medicine 9 (7), 2050	2020
HIV/SARS‐CoV‐2 coinfection: a global perspective ON Kanwugu, P Adadi Journal of medical virology 93 (2), 726-732	2021
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19 M Caterino, M Gelzo, S Sol, R Fedele, A Annunziata, C Calabrese, ... Scientific reports 11 (1), 2941	2021
Molecular basis of the therapeutical potential of clove (Syzygium aromaticum L.) and clues to its anti-COVID-19 utility C Vicidomini, V Roviello, GN Roviello Molecules 26 (7), 1880	2021
Lower COVID-19 mortality in Italian forested areas suggests immunoprotection by Mediterranean plants V Roviello, GN Roviello Environmental chemistry letters 19 (1), 699-710	2021
Drug targets for COVID-19 therapeutics: Ongoing global efforts A Saxena Journal of biosciences 45 (1), 87	2020
Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)? E Levy, E Delvin, V Marcil, S Spahis American Journal of Physiology-Endocrinology and Metabolism 319 (4), E689-E708	2020
A review on SARS-CoV-2 virology, pathophysiology, animal models, and anti-viral interventions SN Neerukonda, U Katneni Pathogens 9 (6), 426	2020
Characteristics and serological patterns of COVID‐19 convalescent plasma donors: optimal donors and timing of donation L Li, X Tong, H Chen, R He, Q Lv, R Yang, L Zhao, J Wang, H Xu, C Liu, ... Transfusion 60 (8), 1765-1772	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。